BioSpace.com News

Cellectis Combined General Shareholders??? Meeting of June 14, 2013

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Alternext: ALCLS) held its Combined General Shareholders Meeting on Friday, June 14, 2013 in Paris, at the Groups headquarters.

Help employers...

Biotage AB - Disclosure Notice of Substantial Holding of Shares

Fri, 14 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Biotage AB (publ) has as of 13 June 2013 bought back an aggregate of 3,574,007shares under the re-purchase program resolved at the Annual General Meeting withthe shareholders on 25 April 2013. The Company...

Elan Corporation PLC Boss Faces Ownership Showdown, Risks Losing $2 Billion if Royalty Pharma Walks

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

When Kelly Martin, a former Merrill Lynch banker with no drug industry experience, took over as CEO of Ireland's Elan (ELN.I) in 2003, analysts assumed his mandate was to clean up the troubled company and sell...

Grant of Warrants to an Employee in Genmab A/S

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; June 12, 2013 Genmab A/S (OMX: GEN) announced today that at a board meeting the board decided to issue 3,000 warrants to an employee of the companys subsidiary.

Help employers...

Following the Announcement 1 May 2013, H. Lundbeck A/S Today Announces the Total Value of the 2013 Long-Term Incentive Programme for Executive Management and Key Employees

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Valby, Copenhagen, 2013-06-07 14:28 CEST (GLOBE NEWSWIRE) -- Following the announcement 1 May 2013, Lundbeck today announces the total value of the 2013 long-term incentive programme for Executive Management...

Biotage AB ??? Changes in Number of Shares and Votes

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

As previously announced, the shareholders resolved at the Annual General Meetingheld on 25 April 2013 to withdraw 3,394,375 shares, which had been repurchasedunder the companys re-purchase program. Following...

Genmab A/S Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; May 31, 2013 Genmab A/S (OMX: GEN) announced today the establishment of a Sponsored Level 1 ADR program in the United States. Deutsche Bank Trust Company Americas will act as the depositary...

Combined Shareholders??? Meeting of Ipsen Held on 31 May 2013

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Regulatory News: The Combined Shareholders Meeting of Ipsen S.A. (Paris:IPN) (Euronext: IPN ; ADR: IPSEY), chaired by Marc de Garidel, Chairman and Chief Executive Officer, was held...

Veloxis Pharmaceuticals A/S ??? Annulment of Warrants and Registration of New Articles of Association Pursuant Thereto

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hrsholm, Denmark, May 30, 2013: Today, the Board of Directors of Veloxis Pharmaceuticals A/S (the "Company") has decided to annul 18,728,293 warrants, which the Company has repurchased from a number of employees...

Bavarian Nordic Establishes a Sponsored Level 1 ADR Program in the U.S.

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

KVISTGAARD, Denmark, May 29, 2013 - Bavarian Nordic A/S (OMX: BAVA) announcedtoday that it has established a sponsored Level 1 American Depositary Receipt(ADR) program in the United States.

Help...

Elan Corporation PLC Announces Pricing of $850 Million in Aggregate Principal Amount of Senior Notes Due 2021

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (Elan) (NYSE: ELN) today announced the pricing of the offering of US$850 million aggregate principal amount of 6.250% Senior Notes due 2021 (the Notes) by its...

3SBio Inc.'s Shareholders Approve Go-Private Transaction

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 24, 2013 -- SBio Inc. will go private. A full 87% of company's shareholders voted in favor of the $16.70 per ADS amended offer. The apparent unanimity is far...

H. Lundbeck A/S ??? Admittance to Trading and Official Listing of New Shares Due to Exercise of Warrants

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The share capital of H. Lundbeck A/S has been increased. The admittance to trading and official listing will take effect on 22 May 2013 in the ISIN below.

Help employers find you! Check out all the...

Prima Biomed Issues the Following Notice to Stockholders of the Company

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SYDNEY, AUSTRALIA--(Marketwired - May 16, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ:

Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the Panel) has granted the Companys request for continued listing...

Galapagos NV Creates New Warrant Plan

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - Galapagos NV (EURONEXT BRUSSELS: GLPG)announced todaythat its Board of Directors created 648,490 warrants under a new...

Elan Corporation PLC Announces Publication of Response Document

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE : ELN) (Elan) today announces publication of a response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) offer made on May 2, ...

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

KVISTGAARD, Denmark, May 16, 2013 - Bavarian Nordic A/S (OMX: BAVA) todaypublishes its first quarter 2013 results. Revenue for the period was DKK 206million (2012: DKK 168 million) and the result before...

Lundbeck Inc. Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-16 11:27 CEST (GLOBE NEWSWIRE) -- Lundbeck increases its share capital by 9,772 shares (0.005% of outstanding shares) as a result of employee warrant exercise.

Help employers find...

Annual General Meeting of Active Biotech AB

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The Annual General Meeting of Active Biotech was held on May 15, 2013. In accordance with the Board of Directors' proposal, it was resolved that nO dividend would be paid.

Help employers find you...

TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Topotarget sends out invitation for shareholder meetings in Copenhagen (Tuesday, June 11, 2013) and Aarhus (Thursday, June 13, 2013).

Help employers find you! Check out all the

Warner Chilcott, PLC Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 13, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "Company") confirms that, as of the close of business on May...

Karolinska Development AB - Interim Report January - March 2013

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM May 10, 2013. Karolinska Development AB (publ) announces publicationof its Interim report January-March, 2013. A conference call will be held todayat 14.00 CET. Participant access numbers: SE...

DiaGenic ASA: Increase in Share Capital

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement from DiaGenic ASA (the "Company")(OSE:DIAG) dated 29 April 2013 regarding the result in the subsequent repair...

Zealand Pharma Announces Amendments to its Articles of Association

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-08 14:30 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand) informs that the companys Articles of Association have been amended.

Help employers...

Notice of Zealand Pharma ???s Interim Report for Q1 2013

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-08 10:21 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand) a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs...

Warner Chilcott, PLC Declares Semi-Annual Cash Dividend of $0.25 Per Share

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 7, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors declared a semi-annual cash dividend in the amount of $0.25 per share, payable June...

Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM May 7, 2013. Karolinska Development will publish its Interim reportfor January March 2013 on Friday, May 10, 2013. The company will also host aconference call and an on-line presentation on...

PledPharma Appoints Advisor for the Commercialization of PledOx®

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Stockholm, 2013-05-06 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma is looking to license PledOx to a major pharmaceutical company with a proven commitment to oncology. The deal structure is expected to include...

Novo Nordisk A/S - Share Repurchase Program

Mon, 06 May 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - May 03, 2013) -

Company Announcement No 34 2013:

http://hugin.info/2013/R/1699315/560490.pdf

This announcement is distributed by Thomson Reuters on behalf of ThomsonReuters clients. The owner of this announcement warrants that:

(i) the releases...

Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Change in the number of votes relating to Biotie Therapies Corp.'s shares

The Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"),Biotie Therapies AG (previously Synosia Therapeutics...

3SBio Inc. Schedules Take-Private Vote for May 24

Fri, 03 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 2, 2013 -- 3SBio Inc. rescheduled the shareholders meeting that will vote on a controversial take-private offer. The meeting is now scheduled to take place on May...

PRANA Biotechnology Announces Share Purchase Plan Closed

Fri, 03 May 2013 12:00:00 AM GMT

MELBOURNE, AUSTRALIA--(Marketwired - May 03, 2013) - Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) is pleased to advise that its Share Purchase Plan (SPP) closed on Friday 26 April 2013 at 5.00 pm (EST) with applications received for 10,370,488 ordinary shares (New Shares).

...

NYSE Liffe Lists Equity Options on Galapagos NV

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BRUSSELS, BELGIUM and MECHELEN, BELGIUM--(Marketwired - April 30, 2013) - Today NYSE Liffe,the Europe-based derivatives business of NYSE Euronext (NYX), addedoptions...

Novo Nordisk A/S - Share Repurchase Program

Tue, 30 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BAGSVAERD, DENMARK--(Marketwired - April 30, 2013) -

Company Announcement No 30 2013:http://hugin.info/2013/R...

Total Number of Voting Rights and Share Capital in Novo Nordisk A/S as of 30 April 2013

Tue, 30 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 30, 2013) -

Company announcement No 31 2013:http://hugin.info/2013/R/1697868/559662.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i)  the releases...

GENFIT Corp.: Conversions Into Shares of 30 Bonds OCA2012-2

Mon, 29 Apr 2013 12:00:00 AM GMT

Lille (France), Boston (Massachusetts, United States), April 29th, 2013 GENFIT (Alternext: ALGFT; ISIN:FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusingon the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announcesthe conversions into shares of 30 bonds OCA2012-2 in keeping with the convertible...

Galapagos NV Completes Private Placement by Issuance of 2,696,831 New Ordinary Shares

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MECHELEN, BELGIUM--(Marketwired - April 29, 2013) - Galapagos NV (EURONEXT BRUSSELS: GLPG)announces that it has completed its capital increase by issuing today2,...

Biotage AB Launches Share Buy-Back

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The board of directors of Biotage AB (publ)(STO:BIOTA) has resolved to start a share buy-back program in accordance with the Annual General Meetings resolution...

Galapagos NV to Raise Capital Via a Private Placement of New Shares

Wed, 24 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Mechelen, Belgium--(Marketwired - April 24, 2013) - Galapagos NV (Euronext: GLPG) todayannounced the launch of a private placement of new shares to institutionalinvestors...

Novo Nordisk A/S - Share Repurchase Program

Mon, 22 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 22, 2013) -

Company Announcement No 29 2013:http://hugin.info/2013/R/1694849/557498.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein...

Novo Nordisk A/S: Reduction of the Share Capital

Mon, 22 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 22, 2013) - At Novo Nordisk's Annual General Meetingon20 March 2013, it was decided to reduce the company's B share capital fromDKK452,512,800 to DKK 442,512,800 by cancellation of part of the company'sportfolio of own B shares at a nominal value of DKK 10,000,000 divided into10,000,000 B shares of DKK 1 each.

Ablynx Announces Warrant Exercise

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GHENT, BELGIUM--(Marketwired - April 22, 2013) -

Highlighted Links

MorphoSys AG to Start Share Buy-Back Program

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MARTINSRIED / MüNCHEN, GERMANY--(Marketwired - April 22, 2013) - MorphoSys AG /MorphoSys to Start Share Buy-Back Program. Processed and transmitted by Thomson Reuters...

Siegfried's Annual Shareholders Meeting Approves All Proposals

Thu, 18 Apr 2013 12:00:00 AM GMT

Zofingen, 18 April 2013 The Annual Shareholders Meeting of Siegfried Holding AG (SIX: SFZN) approved all proposals put forward by the Board of Directors. Profit dis-tribution was increased to CHF 1.20 from CHF 1.00 the previous year, and Colin Bond was appointed to the Board.

The companys 110th Annual Shareholders Meeting was held at the Zofingen City Hall with an attendance of 220 shareholders...

Elan Corporation PLC Announces Final Results of Its Tender Offer

Thu, 18 Apr 2013 12:00:00 AM GMT

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) (Elan) today announced the final results of its modified Dutch auction Tender Offer, to purchase its Ordinary Shares, including Ordinary Shares represented by American Depositary Shares (Shares), up to a maximum aggregate cost of US$1.0 billion, which closed at 8:00 a.m., Irish time, on April 18, 2013.

Ablynx: Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (the "Transparency Law")

Wed, 17 Apr 2013 12:00:00 AM GMT

GHENT, BELGIUM--(Marketwired - April 17, 2013) - Ablynx [Euronext Brussels: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of shareholdings...

Recordati S.p.A: Shareholders Approve the 2012 Accounts. Dividend EUR 0.30 Per Share

Wed, 17 Apr 2013 12:00:00 AM GMT

MILAN, ITALY--(Marketwired - April 17, 2013) -

* Shareholders approve the 2012 results: Consolidated revenue EUR 828.3million, 8.7%, operating income EUR 167.0 million, 2.1%, net income EUR118.5 million, 1.8%.

* Dividend for 2012 EUR 0.30 per share (unchanged compared to thepreceding year's dividend), of which EUR 0.20 already...

WuXi PharmaTech Co., Ltd. Files 2012 Annual Report on Form 20-F

Wed, 17 Apr 2013 12:00:00 AM GMT

SHANGHAI, April 17, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2012 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at

The Special Committee of China Shenghuo Pharmaceutical Holdings, Inc. Accepts Going Private Proposal From Limited at $0.16 per Share to be Effected Through a Reverse Stock Split

Tue, 16 Apr 2013 12:00:00 AM GMT

KUNMING, CHINA--(Marketwired - April 16, 2013) - China Shenghuo Pharmaceutical Holdings, Inc. (PINKSHEETS: CKUN) ("China Shenghuo" or the "Company"), today announced that the special committee consisting solely of independent directors (the "Special Committee") has accepted an offer from Lan's Int'l Medicine...

MorphoSys AG: Announcement of the Convening of the AGM in Munich/Germany on 4 June 2013 According to Sec. 121 Para. 4a AktG With the Objective of Europe-Wide Distribution

Tue, 16 Apr 2013 12:00:00 AM GMT

MARTINSRIED, GERMANY and MUNICH, GERMANY--(Marketwired - April 16, 2013) -

MorphoSys AGMartinsried/PlaneggSecurities Code Numbers: 663200 and A1RFJ5ISIN: DE0006632003 and DE000A1RFJ5

Convenience Translation:

The text decisive for the invitation to the Annual General Meeting ofMorphoSysAG is the one written in the German language...

Gestion Notify of 4.97% Shareholding in Galapagos NV

Mon, 15 Apr 2013 12:00:00 AM GMT

MECHELEN, BELGIUM--(Marketwired - April 12, 2013) - Galapagos NV (Euronext: GLPG) announcedtodaythat it has received a transparency notification pursuant to the Belgiantransparency legislation (Belgian Act of 2 May 2007 on the disclosure ofmajorshareholdings in issuers whose shares are admitted to trading on aregulatedmarket) from Gestion Deelnemingen V...

Novo Nordisk A/S - Share Repurchase Program

Mon, 15 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 15, 2013) -

Company Announcement No 27 2013:http://hugin.info/2013/R/1693091/556430.pdf

This announcement is distributed by Thomson Reuters on behalf of ThomsonReuters clients. The owner of this announcement warrants that:

(i) the releases contained...

TRT Chinese Medicines Expects to IPO on ChiNext

Thu, 11 Apr 2013 12:00:00 AM GMT

by Richard Daverman, PhD

April 10, 2013 -- Tong Ren Tang Technologies Co., a maker of Traditional Chinese Medicines, is moving forward on its long-term plan to spin off and IPO a subsidiary, TRT Chinese Medicine, on the ChiNext exchange, probably within the next three months. TRT Chinese Medicines is Chinas largest exporter of TCM products. Details of the offering are not yet available...

Active Biotech AB - Notice of Annual General Meeting of Shareholders

Thu, 11 Apr 2013 12:00:00 AM GMT

LUND, SWEDEN--(Marketwired - April 11, 2013) - The Board of Directors of Active Biotech AB(publ) has issued a notice to theAnnual General Meeting, which is to take place at 5 p.m. on Wednesday, May15, 2013, at Edison Park, Emdalavägen 16 in Lund, Sweden.

Please see the attached notification, which is being announced within shortinSvenska Dagbladet...

Sunshine Heart Prices $13.1 Million Public Offering of Common Shares

Thu, 11 Apr 2013 12:00:00 AM GMT

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwired - April 11, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) announced today the pricing of its previously announced offering of 2,500,000 shares of its common stock at a price to the public of $5.25 per share in an underwritten public offering pursuant...

Teva Pharmaceutical Industries Limited to Report First Quarter 2013 Financial Results on May 2, 2013

Wed, 10 Apr 2013 12:00:00 AM GMT

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its first quarter 2013 financial results on Thursday, May 2, 2013 at 7:00 a.m. ET.

Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its first quarter 2013 results and overall business environment. A Question & Answer session will follow this discussion.

WuXi PharmaTech Co., Ltd. Schedules First-Quarter 2013 Earnings Release

Wed, 10 Apr 2013 12:00:00 AM GMT

SHANGHAI, April 10, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will...

Galapagos NV Increases Share Capital Through Warrant Exercises

Tue, 09 Apr 2013 12:00:00 AM GMT

MECHELEN, BELGIUM--(Marketwired - April 08, 2013) -

Mechelen, Belgium; 8 April 2013 - Galapagos NV (Euronext: GLPG) announcedtoday a capital increase arising from employee warrant exercises.

Since its inception in 1999, Galapagos has used warrant plans toincentivize personnel and management and have them share in the success ofthe company...

Biostar Pharmaceuticals, Inc. to Host Fiscal 2012 Year End Earnings Conference Call on Monday, April 15, 2013 at 9:30 a.m. ET

Tue, 09 Apr 2013 12:00:00 AM GMT

XIANYANG, China, April 9, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced...

Novo Nordisk A/S - Share Repurchase Program

Mon, 08 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 08, 2013) -

Company Announcement No 26 2013:http://hugin.info/2013/R/1691178/555321.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained...

Elan Corporation PLC Announces Redemption of Its Senior Notes Due 2019

Wed, 03 Apr 2013 12:00:00 AM GMT

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) (the Company) announced today that it has issued an irrevocable Notice of Redemption to redeem all of the $600 million in aggregate principal amount of outstanding 6.25% Senior Notes due 2019 (the Notes) of its wholly owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. The redemption is expected to occur on May ...

Novo Nordisk A/S - Share Repurchase Program

Tue, 02 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 02, 2013) -

Company announcement No 24 / 2013:http://hugin.info/2013/R/1689466/554497.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained...

Novo Nordisk A/S's Holding of Its Own Shares (31 March 2013)

Tue, 02 Apr 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - April 02, 2013) -

Company announcement No 25 / 2013:

http://hugin.info/2013/R/1689500/554511.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases...

Number of Shares and Votes in Active Biotech AB

Thu, 28 Mar 2013 12:00:00 AM GMT

LUND, SWEDEN--(Marketwire - March 28, 2013) - The number of shares and votes in ActiveBiotech has changed as a result of thedirected new issue to Investor as previously announced.

Today, the last trading day of the month, there are in total 74,923,582sharesand votes in Active Biotech.

Lund, March 28, 2013Active Biotech AB (publ)

...

Number of Shares and Votes in Orexo AB

Thu, 28 Mar 2013 12:00:00 AM GMT

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The number of shares and votes in Orexo AB (STO:ORX) has changed as a result of the exercise of warrants. Today, the last trading day of the month, there are in total 30,002,582 shares and votes in the company.

Medgenics, Inc. Announces Exercise by Underwriters of Over-Allotment Option

Tue, 26 Mar 2013 12:00:00 AM GMT

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company or Medgenics), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that, in connection with its previously announced public offering, the underwriters have exercised their...

Novo Nordisk A/S: Share Repurchase Program

Mon, 25 Mar 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwire - March 25, 2013) - Company Announcement No 23 2013:http://hugin.info/2013/R/1687943/553617.pdf

This announcement is distributed by Thomson Reuters on behalf of ThomsonReuters clients. The owner of this announcement warrants that:

(i) the releases contained herein...

Novo Nordisk A/S - Share Repurchase Program

Mon, 18 Mar 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwire - March 18, 2013) - Company Announcement No 20 2013:http://hugin.info/2013/R/1686007/552562.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein...

Covidien plc to Report Second-Quarter Results on April 26, 2013

Thu, 14 Mar 2013 12:00:00 AM GMT

Covidien plc (NYSE: COV) will report second-quarter results on April 26, 2013, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

At Covidiens website: http://investor.covidien.com

MorphoSys AG: Publication Pursuant to SS Sect.1 WpHG (the German Securities Trading Act) With the Aim of Pan-European Distribution

Wed, 13 Mar 2013 12:00:00 AM GMT

MARTINSRIED, GERMANY and MUNCHEN, GERMANY--(Marketwire - March 12, 2013) -

MorphoSys AG /MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the GermanSecuritiesTrading Act) with the aim of pan-European distribution. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

We have...

Elan Corporation PLC Discloses Filing of Share Repurchase Tender Offer Documentation

Wed, 13 Mar 2013 12:00:00 AM GMT

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) (the Company) today disclosed the Tender Offer documentation for the Share Repurchase has been filed and is available on the Companys website at www.elan.com. Consequent on the closing of the previously-announced Tysabri Transaction, Elan will issue an irrevocable Notice of Redemption to redeem all of the outstanding 6.25% Notes due 2019 at...

AEterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013

Tue, 12 Mar 2013 12:00:00 AM GMT

QUEBEC CITY, March 12, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its fourth quarter and full-year 2012 financial and operating results on Thursday, March 21, 2013, after market close. The Company will host a conference...

Novo Nordisk A/S - Share Repurchase Program

Mon, 11 Mar 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwire - March 11, 2013) -

Company Announcement No 18 2013:http://hugin.info/2013/R/1684358/551504.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained...

Ablynx: Publication in Accordance With Articles 14 and 15 of the Belgian Law of 2 May 2007 on the Publication of Major Shareholdings

Mon, 11 Mar 2013 12:00:00 AM GMT

GHENT, BELGIUM--(Marketwire - March 08, 2013) - Ablynx (EURONEXT BRUSSELS: ABLX), the biopharmaceutical company focused on the discovery and development of Nanobodies®, announces today that the closing of its private placement ("Accelerated Bookbuild Offering"/"ABO") took place on 5 March 2013 and as a result, Ablynx issued 4,377,919 new shares. In addition...

Elan Corporation PLC Provides Update on Tysabri Transaction and $1 Billion Share Repurchase

Mon, 11 Mar 2013 12:00:00 AM GMT

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) (the Company) today provides an update on the Tysabri Restructuring Transaction (the Tysabri Transaction) announced on February 6, 2013 and further information regarding the Companys recently announced proposed $1billion share repurchase program. The regulatory closing conditions in connection with the Tysabri Transaction are the review process...

Teva Pharmaceutical Industries Limited Files 2012 Annual Report on Form 20-F

Mon, 11 Mar 2013 12:00:00 AM GMT

JERUSALEM--(BUSINESS WIRE)--In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has filed its 2012 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The Annual Report can be found on the companys website at www.tevapharm.com as well as on the SEC website at www.sec...

DiaGenic ASA: Notification of Trade Among Primary Insiders

Fri, 08 Mar 2013 12:00:00 AM GMT

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement from DiaGenic ASA (DiaGenic or the Company)(OSE:DIAG) on 8 March 2013 regarding the conducted private placement in which the Companys management and members of the board of directors have subscribed and been allocated shares at a subscription price of NOK 0.60 per share. The primary insiders have...

Basilea Pharmaceutica's Board Proposes to Succeed Chairman and Recommends to Shareholders That They do Not Support the Request for a Capital Distribution at This Time

Thu, 07 Mar 2013 12:00:00 AM GMT

BASEL, SWITZERLAND--(Marketwire - March 07, 2013) - Basilea Pharmaceutica AG /Basilea's Board proposes Martin Nicklasson to succeed Chairman WernerHenrichand recommends to shareholders that they do not support the request for acapital distribution at this time. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content...

PuriCore Release: Trading Update for the Year Ended 31 December 2012

Thu, 07 Mar 2013 12:00:00 AM GMT

PuriCore (LSE: PURI), the water-based clean technology company, today announces a trading update for the year ended 31 December 2012. Final results of the Group for this period are expected to be announced 30 April 2013.

Full-Year Financial Highlights (unaudited)

-- Group revenue up 11.3% (12.0% at constant currency) to $47.4m (2011: $42.6m)

o Supermarket Retail...